Blue Bell Private Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
Blue Bell Private Wealth Management's HQL Position: Q3 2026 in Review
Blue Bell Private Wealth Management increased its abrdn Life Sciences Investors (HQL) stake by 14% in Q3 2026, buying an estimated $258K and bringing the position to 105,642 shares worth $1.98M. The position accounts for 0.24% of the portfolio, ranked #81.
Blue Bell Private Wealth Management first reported a position in HQL in Q1 2014 and has held it in 27 quarters since. 82 funds tracked by Wall St. Rank hold HQL as of Q3 2026.
- Blue Bell Private Wealth Management held 105,642 shares of abrdn Life Sciences Investors worth $1.98M as of Q3 2026.
- Blue Bell Private Wealth Management bought 12,743 abrdn Life Sciences Investors shares in Q3 2026, an estimated $258K.
- abrdn Life Sciences Investors made up 0.24% of Blue Bell Private Wealth Management's portfolio in Q3 2026, its #81 holding.
- Blue Bell Private Wealth Management first reported a position in abrdn Life Sciences Investors in Q1 2014 and has held it in 27 quarters since.
- 82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.
Based on Blue Bell Private Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.